Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 4 , Pages 360-367, July 2010

Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma

  • Nitika Badjatia, M.Sc.

      Affiliations

    • Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
  • ,
  • Abhigyan Satyam, M.Sc.

      Affiliations

    • Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
  • ,
  • Prabhjot Singh, M.S.

      Affiliations

    • Department of Urology, All India Institute of Medical Sciences, New Delhi, India
  • ,
  • Amlesh Seth, M.Ch.

      Affiliations

    • Department of Urology, All India Institute of Medical Sciences, New Delhi, India
  • ,
  • Alpana Sharma, Ph.D.

      Affiliations

    • Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
    • Corresponding Author InformationCorresponding author. Tel.: +0091-9899061974; fax: +0091-11-26588641

Received 3 October 2008; received in revised form 1 December 2008; accepted 2 December 2008. published online 27 January 2009.

Abstract 

Objectives

Urothelial carcinoma of bladder is the second most common urological malignancy after prostate cancer. Recently, there has been increased interest in research of the role of free radicals and antioxidant materials in the prevention, treatment, and alleviation of therapy-related side effects of cancer. In the present study, we aimed to assess the alterations in the levels of antioxidant vitamins, activities of defense enzymes, circulating lipid peroxide, and total antioxidant activity (AOA) in patients with urothelial carcinoma of bladder and correlate these changes with the grade and severity of the disease.

Materials and methods

The study cohort consisted of 90 subjects; 50 patients with bladder UC (25, low grade; 10, high grade; 15, muscle invasive) and 40 healthy controls. Vitamins C and E, malondialdehyde (MDA), and AOA were estimated using standard protocols. Superoxide dismutase (SOD) and glutathione peroxidase (GPx) were assayed using commercially available kits.

Results

The serum levels of vitamins C and E, whole blood levels of SOD and GPx, and serum AOA was significantly lower (P < 0.001) while serum MDA levels were significantly higher (P < 0.001) in patients than in controls, indicating presence of oxidative stress in bladder UC patients. The levels of all the biochemical parameters were correlated with the grade and severity of the disease. There were significant differences between the patients with low grade tumors and muscle invasive tumors for all parameters (P < 0.001); except AOA (P < 0.279).

Conclusions

The observed redox imbalance in UC of bladder in correlation with the grade and stage, as a consequence of decreased levels of antioxidant vitamins, enzymes, and AOA, along with increased MDA levels in circulation, may be important factors in tumor development and growth. Our results suggest that with advancing stage of bladder UC, the levels of oxidative stress increase, while levels of antioxidant molecules decrease. These findings suggest possible use of antioxidant supplementation as prophylactic agents for prevention and treatment of bladder cancer.

Keywords: Oxidative stress, Antioxidants, Urinary bladder cancer, Vitamins, SOD, GPx, MDA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was financially supported by Indian Council of Medical Research, New Delhi, India.

PII: S1078-1439(08)00353-0

doi:10.1016/j.urolonc.2008.12.010

Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 4 , Pages 360-367, July 2010